The interaction between TGF-β/Smad3 signalling and GABA may provide new and interesting insights into the molecular mechanisms involved in PD, PD with dementia or even AD, possibly opening new therapeutic strategies for these disorders. Here, SMAD3 is linked to Parkinson disease.